[HTML][HTML] Clinical outcomes of a genomic screening program for actionable genetic conditions

AH Buchanan, HL Kirchner, MLB Schwartz, MA Kelly… - Genetics in …, 2020 - Elsevier
Purpose Three genetic conditions—hereditary breast and ovarian cancer syndrome, Lynch
syndrome, and familial hypercholesterolemia—have tier 1 evidence for interventions that …

Prevalence and properties of intragenic copy-number variation in Mendelian disease genes

R Truty, J Paul, M Kennemer, SE Lincoln… - Genetics in …, 2019 - nature.com
Purpose We investigated the frequencies and characteristics of intragenic copy-number
variants (CNVs) in a deep sampling of disease genes associated with monogenic disorders …

Homologous recombination deficiencies and hereditary tumors

H Yamamoto, A Hirasawa - International journal of molecular sciences, 2021 - mdpi.com
Homologous recombination (HR) is a vital process for repairing DNA double-strand breaks.
Germline variants in the HR pathway, comprising at least 10 genes, such as BRCA1 …

Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations

JD Fackenthal, OI Olopade - Nature Reviews Cancer, 2007 - nature.com
Germline mutations in the BRCA1 or BRCA2 tumour-suppressor genes are strong predictors
of breast and/or ovarian cancer development. The contribution of these mutations to breast …

The BRCA tumor suppressor network in chromosome damage repair by homologous recombination

W Zhao, C Wiese, Y Kwon, R Hromas… - Annual review of …, 2019 - annualreviews.org
Mutations in the BRCA1 and BRCA2 genes predispose afflicted individuals to breast,
ovarian, and other cancers. The BRCA-encoded products form complexes with other tumor …

Genetic predisposition to breast and ovarian cancers: how many and which genes to test?

D Angeli, S Salvi, G Tedaldi - International journal of molecular sciences, 2020 - mdpi.com
Breast and ovarian cancers are some of the most common tumors in females, and the
genetic predisposition is emerging as one of the key risk factors in the development of these …

Genetic/familial high-risk assessment: breast and ovarian

MB Daly, JE Axilbund, S Buys, B Crawford… - Journal of the National …, 2010 - jnccn.org
All cancers develop as a result of mutations in certain genes, such as those involved in the
regulation of cell growth and/or DNA repair, 1, 2 but not all of these mutations are inherited …

[HTML][HTML] Genomic landscape of DNA repair genes in cancer

YK Chae, JF Anker, BA Carneiro, S Chandra… - Oncotarget, 2016 - ncbi.nlm.nih.gov
DNA repair genes are frequently mutated in cancer, yet limited data exist regarding the
overall genomic landscape and functional implications of these alterations in their entirety …

Hereditary cancer syndromes: a comprehensive review with a visual tool

M Garutti, L Foffano, R Mazzeo, A Michelotti, L Da Ros… - Genes, 2023 - mdpi.com
Hereditary cancer syndromes account for nearly 10% of cancers even though they are often
underdiagnosed. Finding a pathogenic gene variant could have dramatic implications in …

BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis

M Oh, A McBride, S Yun, S Bhattacharjee… - JNCI: Journal of the …, 2018 - academic.oup.com
Background Investigations of the associations with colorectal cancer have yielded conflicting
results. The aim of our study was to synthesize the research on colorectal cancer risks in …